launch of policy cures: access to health-related products, technologies and services - professor...
DESCRIPTION
Professor David Heymann, of the London School of Hygiene and Tropical Medicine and Chatham House, explained the recent history of access to health-related products and services and the challenges ahead at the launch of Policy Cures on 16 September 2010. In his presentation he highlighted the cost of malaria – estimated at $12 billion per year –and how the donor community has shifted from the pursuit of a vaccine to providing medicines.TRANSCRIPT
Access to health-related products, technologies and services
David HeymannHead and Senior Fellow, Centre on Global Health Security, Chatham
HouseProfessor of Infectious Disease Epidemiology, London School of Hygiene
and Tropical Medicine
Distribution of deaths by cause and gender, 2004
Source: GBD, WHO 2004
Child mortality rates by cause and region, 2004
Source: GBD 2004, WHO
~ 1 million deaths per year
Estimated malaria incidence per 1000 population, 2006
Source: World Malaria Report, 2008 In addition to human suffering and death, an estimated US$ 12 billion lost each year from direct and indirect costs
Effective evidence-based interventions: Malaria
Reduce exposure to mosquitoes
Prompt diagnosis
Prompt treatment in children, and intermittent treatment in pregnant women
Source: WHO
Development agencies and health, before 2000
“Medicines not sustainable….the only
cost effective interventions are vaccines”
WHO Commission on Macroeconomics and Health
Macroeconomics and HealthCommissioners
Access to medicines: The Global Fund, funding 2001 - 2009
0
1
2
3
4
2001-2004
2006 20082005 2007 2009
Billio
ns o
f dol
lars
US
Year
US$ 2.6 billion to malaria programmes in 85
countries
Other contributions to access to medicines and vaccines
……….
The Global Fund: long term sustainability
Source: New York Times, May 2010
GAVI: long term sustainability
Source: The Lancet Vol 375:9117. 791, 6 March 2010
Non-communicable diseases
Non-communicable diseases are increasing burden in all countries
Diabetes, a non-communicable disease with high mortality
Cost of care for diabetics, recent estimates
What are the sustainable models for increasing access to medicines, vaccines and other health-related technologies
Access to health-related products, technologies and services